Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Depression treatment with duloxetine and reduction of inability to work.

Happich M, Schneider E, Wilhelm S, Zimmermann T, Schacht A.

Depress Res Treat. 2012;2012:264854. doi: 10.1155/2012/264854. Epub 2012 Aug 2.

2.

A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.

Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Marangell LB.

Curr Med Res Opin. 2011 Oct;27(10):1849-58. doi: 10.1185/03007995.2011.609539. Epub 2011 Aug 12.

PMID:
21838411
3.

Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.

Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Hann D, Marangell LB.

Curr Med Res Opin. 2011 Oct;27(10):1859-67. doi: 10.1185/03007995.2011.609540. Epub 2011 Aug 12.

PMID:
21838410
4.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
5.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
6.

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.

J Psychiatr Res. 2005 Jan;39(1):43-53.

PMID:
15504423
7.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

8.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
9.

Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.

Cui Z, Faries DE, Zhao Y, Novick D, Liu X.

J Med Econ. 2011;14(5):662-72. doi: 10.3111/13696998.2011.611060. Epub 2011 Sep 5.

PMID:
21892857
10.

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.

Shelton RC, Andorn AC, Mallinckrodt CH, Wohlreich MM, Raskin J, Watkin JG, Detke MJ.

Int Clin Psychopharmacol. 2007 Nov;22(6):348-55.

PMID:
17917553
11.

Time course of depression-symptom improvement during treatment with duloxetine.

Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ.

Depress Anxiety. 2005;21(4):170-7.

PMID:
16035056
12.

Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.

Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.

Clin J Pain. 2009 Jul-Aug;25(6):461-8. doi: 10.1097/AJP.0b013e318197d4e4.

PMID:
19542792
13.
14.

Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.

Gaynor P, McCarberg B, Zheng W, Shoemaker S, Duenas H.

Int J Clin Pract. 2011 Mar;65(3):341-9. doi: 10.1111/j.1742-1241.2011.02635.x. Review.

PMID:
21314871
15.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.

J Clin Psychiatry. 2006 May;67(5):761-70.

PMID:
16841626
16.

The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.

Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.

Ann Clin Psychiatry. 2008 Oct-Dec;20(4):187-93. doi: 10.1080/10401230802435609.

PMID:
19034749
17.

Duloxetine use in chronic low back pain: treatment patterns and costs.

Ivanova JI, Birnbaum HG, Kantor E, Schiller M, Swindle RW.

Pharmacoeconomics. 2012 Jul 1;30(7):595-609. doi: 10.2165/11598130-000000000-00000.

PMID:
22686662
18.

Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM.

J Psychiatr Res. 2006 Jun;40(4):337-48. Epub 2005 Nov 4.

PMID:
16271726
19.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128
20.

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.

Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.

Depress Anxiety. 2007;24(1):41-52.

PMID:
16845641

Supplemental Content

Support Center